Cargando…

OA021-05. Insertion of the HIV-1 gp41 epitopes 2F5 and 4E10 into the membrane-proximal region of the vesicular stomatitis virus glycoprotein

Detalles Bibliográficos
Autores principales:	Lorenz, IC, Nguyen, HT, Phogat, SK, Kaminsky, SM, Zamb, TJ, Parks, CL
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767537/ http://dx.doi.org/10.1186/1742-4690-6-S3-O17

Ejemplares similares

P12-14. Design of hydrophilic, helical peptides that mimic the 4E10 epitope of HIV-1 gp41
por: Lorenz, IC, et al.
Publicado: (2009)

S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
por: Song, L, et al.
Publicado: (2009)

S021-06 OA. Potent and broad neutralizing antibodies from HIV-1 non-clade B infected donor reveal a new HIV-1 vaccine target
por: Phogat, SK, et al.
Publicado: (2009)

OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies
por: Shen, X, et al.
Publicado: (2009)

TRIM41-Mediated Ubiquitination of Nucleoprotein Limits Vesicular Stomatitis Virus Infection
por: Patil, Girish, et al.
Publicado: (2020)

Aphthæ, or Vesicular Stomatitis of the Horse
por: Hutcheon, D.
Publicado: (1898)

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
por: Clarke, David K., et al.
Publicado: (2006)

The synthetic futures of vesicular stomatitis virus
por: Overend, Christopher, et al.
Publicado: (2012)

EFFECT OF FORMALIN ON THE VIRUS OF VESICULAR STOMATITIS OF HORSES
por: Olitsky, Peter K., et al.
Publicado: (1928)

Transmembrane biogenesis of the vesicular stomatitis virus glycoprotein
Publicado: (1979)

Vesicular stomatitis forecasting based on Google Trends
por: Wang, JianYing, et al.
Publicado: (2018)

OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines
por: Jacobs, B, et al.
Publicado: (2009)

OA021-03. Design and development of DNA vaccines for the co-expression of micro-RNA and HIV-1 Env
por: Wheatley, AK, et al.
Publicado: (2009)

S021-04 OA. A large-scale analysis of immunoglobulin sequences derived from plasmablasts/plasma cells in acute HIV-1 infection subjects
por: Munshaw, S, et al.
Publicado: (2009)

Tamoxifen Protects from Vesicular Stomatitis Virus Infection
por: Cham, Lamin B., et al.
Publicado: (2019)

Effect of sulfhydryl reagents on the infectivity of vesicular stomatitis virus
por: Beatrice, Sara T., et al.
Publicado: (1980)

TRIM69 Inhibits Vesicular Stomatitis Indiana Virus
por: Rihn, Suzannah J., et al.
Publicado: (2019)

Atomic model of vesicular stomatitis virus and mechanism of assembly
por: Zhou, Kang, et al.
Publicado: (2022)

Emerging Biomedical Applications of the Vesicular Stomatitis Virus Glycoprotein
por: Rehman, Sheeba, et al.
Publicado: (2022)

Elicitation of neutralizing antibodies by intranasal administration of recombinant vesicular stomatitis virus expressing human immunodeficiency virus type 1 gp120
por: Jiang, Pengfei, et al.
Publicado: (2006)

COMPARATIVE STUDIES ON THE VIRUSES OF VESICULAR STOMATITIS AND EQUINE ENCEPHALOMYELITIS (1)
por: Olitsky, Peter K., et al.
Publicado: (1934)

Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses
Publicado: (1981)

Structure of the Vesicular Stomatitis Virus N(0)-P Complex
por: Leyrat, Cédric, et al.
Publicado: (2011)

Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
por: Bishnoi, Suman, et al.
Publicado: (2018)

Evaluating Temperature Sensitivity of Vesicular Stomatitis Virus–Based Vaccines
por: Stein, Derek R., et al.
Publicado: (2019)

Vesicular Stomatitis Virus Transmission: A Comparison of Incriminated Vectors
por: Rozo-Lopez, Paula, et al.
Publicado: (2018)

Venereal Transmission of Vesicular Stomatitis Virus by Culicoides sonorensis Midges
por: Rozo-Lopez, Paula, et al.
Publicado: (2020)

Vesicular Stomatitis Virus: From Agricultural Pathogen to Vaccine Vector
por: Liu, Guodong, et al.
Publicado: (2021)

Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We?
por: Zhang, Yuguo, et al.
Publicado: (2022)

Depletion and reconstitution of macrophages in mice with vesicular stomatitis virus infection
por: Wang, Yingchun, et al.
Publicado: (2023)

Identification of epitopes associated with different biological activities on the glycoprotein of vesicular stomatitis virus by use of monoclonal antibodies
por: Nagata, S., et al.
Publicado: (1992)

P12-04. Topology of the C-terminal tail of HIV-1 gp41: Differential exposure of the Kennedy epitope on cell and viral membranes
por: Steckbeck, JD, et al.
Publicado: (2009)

P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes
por: Matyas, GR, et al.
Publicado: (2009)

gp41: HIV's shy protein
por: Zwick, Michael B, et al.
Publicado: (2004)

Enhancing Exposure of HIV-1 Neutralization Epitopes through Mutations in gp41
por: Blish, Catherine A, et al.
Publicado: (2008)

Assessing the protective efficacy of antibodies to the HIV gp41 region by active vaccination
por: Sharma, SK, et al.
Publicado: (2012)

LBODP021 Multifactorial Hypercalcemia
por: Ramachandran, Aishwarya, et al.
Publicado: (2022)

Different Effect of Proteasome Inhibition on Vesicular Stomatitis Virus and Poliovirus Replication
por: Neznanov, Nickolay, et al.
Publicado: (2008)

ELECTRON MICROSCOPIC STUDIES ON THE DEVELOPMENT OF VESICULAR STOMATITIS VIRUS IN KB CELLS
por: Mussgay, M., et al.
Publicado: (1963)

Cellular Proteins Associated with the Interior and Exterior of Vesicular Stomatitis Virus Virions
por: Moerdyk-Schauwecker, Megan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5bftek1ufp0dvlvbgacm3jj9mp